Defense Health Agency Contracting Activity - DHACA

Description

The OCRP Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. These data may be unpublished or from the published literature. If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s).Clinical trials are not supported with this award mechanism.New for FY21 is the Partnering PI Option: As a method to facilitate progress in addressing critical problems or questions through collaborative efforts, the FY21 OCRP is offering a Partnering PI Option for this award mechanism. The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, work synergistically on a single project. If recommended for funding, each PI will be named to an individual award within the recipient organization.

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org